MacroGenics Inc.
Organization details
- Legal name
- MacroGenics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Rockville
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MGNX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001125345
Board of directors
-
David C. Stump · DirectorSince 2023
-
Edward Hurwitz · DirectorSince 2023
-
Emil Kuriakose · DirectorSince 2026
-
Eric Blasius Risser · Director · President and CEOSince 2025
-
Federica F. O'Brien · DirectorSince 2023
-
Jay Philip Siegel · DirectorSince 2023
-
Karen Jean Ferrante · DirectorSince 2023
-
Margaret Liu · DirectorSince 2023
-
Meenu Chhabra · DirectorSince 2023
-
Michael Vasconcelles · DirectorSince 2026
-
Scott Koenig · Director · President and CEOSince 2023
-
Scott Thomas Jackson · DirectorSince 2023
-
William K. Heiden · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.4%
-
96.8%
-
99.4%
Board connections
8 of this board's directors also sit on 8 other boards. 8 are in the same sector.
-
Crescent Biopharma Inc. Same sectorvia Scott Koenig and Scott Thomas Jackson
-
Atara Biotherapeutics Inc. Same sectorvia William K. Heiden
-
Cogent Biosciences Inc. Same sectorvia Karen Jean Ferrante
-
Dyne Therapeutics Inc. Same sectorvia Edward Hurwitz
-
Kura Oncology Inc. Same sectorvia Michael Vasconcelles
-
REGENXBIO Inc. Same sectorvia David C. Stump
-
Spero Therapeutics Inc. Same sectorvia Scott Thomas Jackson
-
TELA Bio Inc. Same sectorvia Federica F. O'Brien
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $129,086
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 6, 2026 | Bonvini Ezio Officer (Sr VP, Research & CSO) | Option exercise | +8,000 | $2.60 | $20,800 |
| Aug 19, 2026 | Peters Jeffrey Stuart Officer (Senior VP, GC, and Secretary) | Open-market sale | −31,105 | $4.15 | $129,086 |
| Aug 17, 2026 | Bonvini Ezio Officer (Sr VP, Research & CSO) | Option exercise | +40,000 | $2.60 | $104,000 |
| May 18, 2026 | Federica F. O'Brien Director | Option exercise | +3,750 | — | — |
| May 18, 2026 | Scott Thomas Jackson Director | Option exercise | +3,750 | — | — |
| May 18, 2026 | William K. Heiden Director | Option exercise | +3,750 | — | — |
| May 18, 2026 | Jay Philip Siegel Director | Option exercise | +3,750 | — | — |
| May 18, 2026 | Margaret Liu Director | Option exercise | +3,750 | — | — |
| May 18, 2026 | Meenu Chhabra Director | Option exercise | +3,750 | — | — |
| May 18, 2026 | Edward Hurwitz Director | Option exercise | +3,750 | — | — |
| May 18, 2026 | David C. Stump Director | Option exercise | +3,750 | — | — |
| May 18, 2026 | Karen Jean Ferrante Director | Option exercise | +3,750 | — | — |
| Feb 15, 2026 | Bonvini Ezio Officer (Sr VP, Research & CSO) | Option exercise | +16,665 | — | — |
| Feb 15, 2026 | Smith Beth Ann Officer (VP, Controller & Treasurer) | Option exercise | +1,095 | — | — |
| Feb 15, 2026 | Karrels James Officer (SVP and CFO) | Option exercise | +14,999 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about MacroGenics Inc.
Who is the CEO of MacroGenics Inc.?
Scott Koenig is MacroGenics Inc.'s President and CEO.
How many directors are on MacroGenics Inc.'s board?
MacroGenics Inc.'s board has 13 directors: David C. Stump, Edward Hurwitz, Emil Kuriakose, Eric Blasius Risser, Federica F. O'Brien, Jay Philip Siegel, Karen Jean Ferrante, Margaret Liu, Meenu Chhabra, Michael Vasconcelles and 3 others.
Are MacroGenics Inc. insiders buying or selling shares?
Over the last 12 months, MacroGenics Inc. insiders made no open-market purchases and sold $129,086 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="macrogenics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.